(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Chris A Raanes \u0010President/CEO \u0010Viewray Inc \u0010Will discuss the rollout of their cancer treatment, MRIdian, which can both image, and treat cancer patients at the same time.

<p>(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Chris A Raanes \u0010President/CEO \u0010Viewray Inc \u0010Will discuss the rollout of their cancer treatment, MRIdian, which can both image, and treat cancer patients at the same time.</p>

Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

<p>Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.</p>

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Raanes on Rollout of Cancer Treatment (Audio)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/1de9ee5a-810f-43ab-aa96-ae3c008f2588/transcript

Advertisement